Some of the studies evaluated in this systematic review focus on children, associating a higher frequency of CD36-positive cells at diagnosis in children who experienced recurrence of AML26; therefore, studies comparing the role of CD36 in AML in different age ranges have not been done. The gene discussed is CD36; the disease is acute myeloid leukemia.